subscribeSubscribe
price-trendAsk Us
Guardant Health & Blueprint Medicines present real-world data at IASLC 2022

Guardant Health & Blueprint Medicines present real-world data at IASLC 2022
BUSINESS WIRE
08 Aug 2022
Share Share
InnoCare Announces 1st Subject Dosed in Clinical Trial of TYK2 JH2

InnoCare Announces 1st Subject Dosed in Clinical Trial of TYK2 JH2
BUSINESSWIRE
01 Aug 2022
Share Share
InnoCare`s Clinical Trial of ICP-189 gets approval in China

InnoCare`s Clinical Trial of ICP-189 gets approval in China
PRNEWSWIRE
19 Oct 2021
Share Share
Antifungal out, cancer in: Revolution scores $500M Sanofi deal

Antifungal out, cancer in: Revolution scores $500M Sanofi deal
Brittany Meiling ENDPTS
18 Jul 2018
Share Share
Exelixis links with BMS to test potential cancer combo

Exelixis links with BMS to test potential cancer combo
Selina McKee PHARMATIMES
01 Mar 2017
Share Share
BMS buys back early oncology rights from Asia partner

BMS buys back early oncology rights from Asia partner
Stacy Lawrence FIERCE BIOTECH
11 Aug 2016
Share Share
Could Common Diabetes Drugs Help Fight Leukemia?

Could Common Diabetes Drugs Help Fight Leukemia?
Maureen Salamon WEBB MD
02 Sep 2015
Share Share
Recall: Baxter`s Clinimix (2015-06-19)

Recall: Baxter`s Clinimix (2015-06-19)
HEALTHY CANADIANS
12 Jun 2015
Share Share